Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Østergaard

Showing results (281-290 of 403) with videos related to

Pageof 41
Sort By:
The Journal of Rheumatology|February 17, 2015
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research PrioritiesMikkel Østergaard, Paul Bird, Frédérique Gandjbakhch, et al.
ACR Open Rheumatology|August 29, 2025
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid ArthritisTilia Selldén, Kristina Lend, Jon Lampa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada MethodsSusanne J Pedersen, Denis Poddubnyy, Inge J Sørensen, et al.
BMJ Open|June 7, 2019
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled studyOliver Hendricks, Tonny Elmose Andersen, Afshin Ashouri Christiansen, et al.
Lancet (London, England)|December 10, 2019
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trialAtul Deodhar, Désirée van der Heijde, Lianne S Gensler, et al.
RMD Open|June 6, 2025
Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trialKristina Lend, Jos Wr Twisk, Nupur Kumar, et al.
RMD Open|June 23, 2020
Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS)Ashish J Mathew, Simon Krabbe, Iris Eshed, et al.
The Journal of Rheumatology|June 17, 2017
Whole-body Magnetic Resonance Imaging in Inflammatory Arthritis: Systematic Literature Review and First Steps Toward Standardization and an OMERACT Scoring SystemMikkel Østergaard, Iris Eshed, Christian E Althoff, et al.
Trials|September 5, 2022
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trialDafna D Gladman, Philip J Mease, Paul Bird, et al.
Frontiers in Immunology|March 31, 2022
The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental SettingsStinne R Greisen, Tue W Kragstrup, Jesper Skovhus Thomsen, et al.
Pageof 41

Showing results (281-290 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Rheumatology|February 17, 2015
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research PrioritiesMikkel Østergaard, Paul Bird, Frédérique Gandjbakhch, et al.
ACR Open Rheumatology|August 29, 2025
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid ArthritisTilia Selldén, Kristina Lend, Jon Lampa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada MethodsSusanne J Pedersen, Denis Poddubnyy, Inge J Sørensen, et al.
BMJ Open|June 7, 2019
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled studyOliver Hendricks, Tonny Elmose Andersen, Afshin Ashouri Christiansen, et al.
Lancet (London, England)|December 10, 2019
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trialAtul Deodhar, Désirée van der Heijde, Lianne S Gensler, et al.
RMD Open|June 6, 2025
Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trialKristina Lend, Jos Wr Twisk, Nupur Kumar, et al.
RMD Open|June 23, 2020
Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS)Ashish J Mathew, Simon Krabbe, Iris Eshed, et al.
The Journal of Rheumatology|June 17, 2017
Whole-body Magnetic Resonance Imaging in Inflammatory Arthritis: Systematic Literature Review and First Steps Toward Standardization and an OMERACT Scoring SystemMikkel Østergaard, Iris Eshed, Christian E Althoff, et al.
Trials|September 5, 2022
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trialDafna D Gladman, Philip J Mease, Paul Bird, et al.
Frontiers in Immunology|March 31, 2022
The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental SettingsStinne R Greisen, Tue W Kragstrup, Jesper Skovhus Thomsen, et al.
Pageof 41